Carpal tunnel decompression surgery has few serious complications

By

By Lisa Rapaport

(Reuters Health) - Carpal tunnel decompression surgery rarely results in serious complications or reoperations, a U.K. study suggests.

Researchers examined data on 855,832 carpal tunnel decompression surgeries done for adults with National Health Service coverage between 1998 and 2017.

Overall, just 620 surgeries (0.07%) led to serious complications such as surgical site infection or dehiscence, or neurovascular or tendon injury leading to readmission or reoperation within 30 days. Within 90 days, this rose to 698 procedures (0.082%) with serious complications.

A total of 29,288 surgeries led to reoperation (incidence rate 3.18 per 1,000 person-years).

"This study captures all the carpal tunnel surgeries that were paid for within all NHS hospitals over a 19 year period, which means that the results here are generalizable to all patients that present within a nationalized healthcare service," said lead study author Jennifer Lane of the University of Oxford in the U.K.

"Since we had such a broad inclusion criteria, and since many carpal tunnel surgeries are undertaken in England each year, we don't believe the low rates of serious complications are due to patient selection, but that the procedure is safe compared to other interventions," Lane said by email.

The 90-day complication rates were higher for male patients (adjusted subhazard ratio 2.32), and for patients ages 18-29, compared to older individuals (aSR 2.25).

The most common serious postoperative complications were wound dehiscence (0.030% and 0.033% at 30 and 90 days, respectively); tendon injury (0.028% and 0.033% at 30 and 90 days, respectively); neurovascular injury (0.010% at 30 and 90 days); and wound infection (0.0037% and 0.0050% at 30 and 90 days, respectively).

Men also had higher risk for reoperation (aSR 1.09), as did patients over age 80 compared to patients ages 50-59 (aSR 1.09). More comorbidities were also tied to higher reoperation risk (aSR 1.25 for Charleston score of 5 or more vs Charleston score of 0).

Minor complications including wound infections treated in primary care were not tracked, and might contribute to an underestimation of infection rates and local complication rates.

Another drawback is that the administrative NHS data used for the analysis might not track certain complications like regional pain syndrome or scar tenderness, the study team notes in The Lancet Rheumatology.

Even so, the findings can be used to inform patient decisions about surgery and to inform national health policy, the study team writes.

SOURCE: https://bit.ly/31fhm2g Lancet Rheumatology, online September 30, 2020.

Related Articles

REFILE-Per-oral endoscopic myotomy "reasonable" first-line treatment for idiopathic achalasia

(Corrects spelling of researcher's name, to Mundre, in paras 2 and 4 of Oct 19 story.) By Marilynn Larkin NEW YORK (Reuters Health) - Per-oral endoscopic myotomy (POEM) has comparable efficacy to Read More »

Local estrogen therapy for vaginal atrophy can start before or after age 60

By Marilynn Larkin NEW YORK (Reuters Health) - Treatment with low-dose local estrogen therapy (ET) to improve symptoms of vaginal atrophy may start before or after age 60, according to a post-hoc Read More »

DVT screening, early treatment, prevent PE in necrotizing pancreatitis

By Marilynn Larkin NEW YORK (Reuters Health) - Ultrasound screening enabled identification and early treatment of extremity deep vein thrombosis (DVT), thereby preventing symptomatic pulmonary Read More »


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information